Julie Zaidler
About Julie Zaidler
Julie Zaidler is the Associate Director of WW Oncology Early Assets & Diagnostics at Bristol Myers Squibb, with over 15 years of experience in market research and a background in psychology and business administration.
Title
Julie Zaidler is currently the Associate Director of Worldwide (WW) Oncology Early Assets & Diagnostics at Bristol Myers Squibb.
Company
Julie Zaidler presently works at Bristol Myers Squibb, a global biopharmaceutical company known for its work in oncology and immunology. She has been with the company since August 2017.
Education and Expertise
Julie Zaidler earned her MBA in Marketing and Finance from NYU Stern School of Business, where she studied from 2004 to 2007. She also holds a BA/MA in Psychology from Wesleyan University, which she completed from 1992 to 1996. She has over 15 years of experience in both qualitative and quantitative market research, and excels at integrating primary research findings with secondary data to provide actionable business solutions.
Professional Background
Before joining Bristol Myers Squibb, Julie Zaidler worked at AstraZeneca as Insight Lead for Immuno-Oncology & Diabetes from 2015 to 2017. Prior to that, she spent six years at Forest Laboratories as Market Research Manager for Cardiovascular & Neurology from 2008 to 2014, and four years as a Senior Research Analyst for Pain & Inflammation from 2004 to 2008. She also has experience as Project Director at Harris Interactive, Project Manager at Shachtman Fagan Inc., and Research Analyst/Sr. Research Analyst at Jobson Publishing.
Industry Experience
Julie Zaidler possesses a solid understanding of both the vendor and client sides of business. Her extensive career spans roles in market research management and project direction in notable pharmaceutical and healthcare research companies. These roles have honed her skills in conducting and integrating comprehensive market research to produce insightful business solutions.